russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2024-5694russjcardiol-5694Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWРеваскуляризация миокарда у пациентов с кальцинозом коронарных артерий: систематический обзор и метаанализMyocardial revascularization in patients with coronary artery calcification: a systematic review and meta-analysishttps://orcid.org/0000-0003-0737-7698ПашаевР. А.PashayevR. A.

Пашаев Р. А. - аспирант ОССХ

Москва

Moscow

rasul.568@mail.ruhttps://orcid.org/0000-0002-3325-9743ШиряевА. А.ShiryaevA. A.

Ширяев А. А. - д.м.н., профессор, член-корр. РАН, руководитель лаборатории микрохирургии сердца и сосудов ОССХ

Москва

Moscow

https://orcid.org/0000-0002-2323-4059Миронов.В. М.MironovV. M.

Миронов В. М. - к.м.н., врач отделения рентгенохирургических методов диагностики и лечения

Москва

Moscow

https://orcid.org/0000-0001-7767-1695КурбановС. К.KurbanovS. K.

Курбанов С. К. - к.м.н., врач кардиолог, м.н.с. лаборатории микрохирургии сердца и сосудов

Москва

Moscow

https://orcid.org/0000-0003-2925-244XВласоваЭ. Е.VlasovaE. E.

Власова Э. Е. - к.м.н, врач кардиолог, с.н.с. лаборатории микрохирургии сердца и сосудов ОССХ

Москва

Moscow

https://orcid.org/0000-0002-8438-2450ГанаевК. Г.GanayevK. G.

Ганаев К. Г. - к.м.н., врач кардиолог, м.н.с. лаборатории микрохирургии сердца и сосудов ОССХ

Москва

Moscow

https://orcid.org/0009-0006-4727-4959КурбановГ. М.KurbanovG. M.

Курбанов Г. М. - аспирант ОССХ

Москва

Moscow

https://orcid.org/0000-0001-7759-049XАндреевА. В.AndreyevA. V.

Андреев А. В. - к.м.н., зав. операционным блоком, врач сердечно-сосудистый хирург ОССХ

Москва

Moscow

https://orcid.org/0000-0002-2297-6026ВасильевВ. П.VasilyevV. P.

Васильев В. П. - к.м.н., с.н.с. лаборатории микрохирургии сердца и сосудов, врач сердечно-сосудистый хирург, зав. ОССХ

Москва

Moscow

https://orcid.org/0000-0002-0257-1398ГаляутдиновД. М.GalyautdinovD. M.

Галяутдинов Д. М. - к.м.н., с.н.с. лаборатории искусственного и вспомогательного кровообращения, врач сердечно-сосудистый хирург ОССХ

Москва

Moscow

https://orcid.org/0000-0002-2105-8258АкчуринР. С.AkchurinR. S.

Акчурин Р. С. - д.м.н., профессор, академик РАН, зам. генерального директора по хирургии и руководитель отдела ОССХ

Москва

Moscow

ФГБУ Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова Минздрава РоссииРоссияChazov National Medical Research Center of CardiologyRussian Federation2024310820242911SОбзоры литературы, мнение по проблеме56945694Copyright © Пашаев Р.А., Ширяев А.А., Миронов. В.М., Курбанов С.К., Власова Э.Е., Ганаев К.Г., Курбанов Г.М., Андреев А.В., Васильев В.П., Галяутдинов Д.М., Акчурин Р.С., 20242024Пашаев Р.А., Ширяев А.А., Миронов. В.М., Курбанов С.К., Власова Э.Е., Ганаев К.Г., Курбанов Г.М., Андреев А.В., Васильев В.П., Галяутдинов Д.М., Акчурин Р.С.Pashayev R.A., Shiryaev A.A., Mironov V.M., Kurbanov S.K., Vlasova E.E., Ganayev K.G., Kurbanov G.M., Andreyev A.V., Vasilyev V.P., Galyautdinov D.M., Akchurin R.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/5694Цель

Цель. Анализ и обобщение госпитальных результатов реваскуляризации миокарда у больных с кальцинозом коронарных артерий.

Материал и методы

Материал и методы. При первичном отборе найдено 470 публикаций, среди которых 354 из базы Pubmed на английском языке и 116 из базы E-library на русском языке. Отобрано 13 исследований, соответствующих критериям поиска. Среди них 5 исследований для коронарного шунтирования (n=932) и 8 для эндоваскулярного вмешательства (n=5758). В качестве конечных точек изучена 30-дневная смертность и периоперационный инфаркт миокарда (ПИМ).

Результаты

Результаты. Встречаемость ПИМ у больных с кальцинозом коронарных артерий при проведении чрескожного коронарного вмешательства с использованием методик атерэктомии составляет 4,4%, госпитальная смертность - 0,9%. Встречаемость ПИМ при коронарном шунтировании с использованием сложных коронарных реконструкции в этой группе больных составляет 2,6%, госпитальная смертность - 0,7%.

Заключение

Заключение. Реваскуляризация миокарда больных с коронарным кальцинозом может быть выполнена эндоваскулярным и открытым способом с использованием расширенных методик коронарной реконструкции. Госпитальные результаты представляются удовлетворительными, выводы о преимуществах того или иного метода требуют проведения сравнительных исследований.

Aim

Aim. To analyze and generalize inhospital outcomes of myocardial revascularization in patients with coronary artery calcification.

Material and methods

Material and methods. The primary selection yielded 470 publications, including 354 from the Pubmed database in English and 116 from the E-library database in Russian. Thirteen studies were selected that met the search criteria. Among them, 5 studies were for coronary artery bypass grafting (n=932) and 8 for endovascular intervention (n=5758). The endpoints were 30-day mortality and perioperative myocardial infarction (PMI).

Results

Results. PMI incidence in patients with coronary artery calcification in percutaneous coronary intervention using atherectomy techniques is 4,4%, while inhospital mortality - 0,9%. PMI incidence in coronary artery bypass grafting using complex coronary interventions in this group of patients is 2,6%, while inhospital mortality - 0,7%.

Conclusion

Conclusion. Myocardial revascularization in patients with coronary calcification can be performed by endovascular and open approaches using advanced coronary surgery techniques. Inhospital outcomes seem satisfactory. Conclusions about the advantages of one method or another require comparative studies.

кальциноз коронарных артерийреконструкция коронарных артерийcoronary artery calcificationcoronary artery reconstructionReferencesErtelt K, Généreux P, Mintz GS, et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol. 2013;112(11):1730-7. doi:10.1016/j.amjcard.2013.07.038.Ertelt K, Généreux P, Mintz GS, et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol. 2013;112(11):1730-7. doi:10.1016/j.amjcard.2013.07.038.Bourantas CV, Zhang YJ, Garg S, et al. Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX study. Catheter Cardiovasc Interv. 2015;85(2):199-206. doi:10.1002/ccd.25545.Bourantas CV, Zhang YJ, Garg S, et al. Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX study. Catheter Cardiovasc Interv. 2015;85(2):199-206. doi:10.1002/ccd.25545.Kawashima H, Serruys PW, Hara H, et al.; SYNTAX Extended Survival Investigators. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2022;15(2):193-204. doi:10.1016/j.jcin.2021.10.026.Kawashima H, Serruys PW, Hara H, et al.; SYNTAX Extended Survival Investigators. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2022;15(2):193-204. doi:10.1016/j.jcin.2021.10.026.Bangalore S, Vlachos HA, Selzer F, et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2011;77(1):22-8. doi:10.1002/ccd.22613.Bangalore S, Vlachos HA, Selzer F, et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2011;77(1):22-8. doi:10.1002/ccd.22613.Tian W, Lhermusier T, Minha S, et al. Rational use of rotational atherectomy in calcified lesions in the drug-eluting stent era: Review of the evidence and current practice. Cardiovasc Revasc Med. 2015;16(2):78-83. doi:10.1016/j.carrev.2014.12.011.Tian W, Lhermusier T, Minha S, et al. Rational use of rotational atherectomy in calcified lesions in the drug-eluting stent era: Review of the evidence and current practice. Cardiovasc Revasc Med. 2015;16(2):78-83. doi:10.1016/j.carrev.2014.12.011.Bulluck H, McEntegart M. Contemporary tools and devices for coronary calcium modification. JRSM Cardiovasc Dis. 2022;11:20480040221089760. doi:10.1177/20480040221089760.Bulluck H, McEntegart M. Contemporary tools and devices for coronary calcium modification. JRSM Cardiovasc Dis. 2022;11:20480040221089760. doi:10.1177/20480040221089760.Villanueva EV, Wasiak J, Petherick ES. Percutaneous transluminal rotational atherectomy for coronary artery disease. Cochrane Database Syst Rev. 2003;(4):CD003334. doi:10.1002/14651858.CD003334.Villanueva EV, Wasiak J, Petherick ES. Percutaneous transluminal rotational atherectomy for coronary artery disease. Cochrane Database Syst Rev. 2003;(4):CD003334. doi:10.1002/14651858.CD003334.Soylu E, Harling L, Ashrafian H, et al. Adjunct coronary endarterectomy increases myocardial infarction and early mortality after coronary artery bypass grafting: a metaanalysis. Interact Cardiovasc Thorac Surg. 2014;19(3):462-73. doi:10.1093/icvts/ivu157.Soylu E, Harling L, Ashrafian H, et al. Adjunct coronary endarterectomy increases myocardial infarction and early mortality after coronary artery bypass grafting: a metaanalysis. Interact Cardiovasc Thorac Surg. 2014;19(3):462-73. doi:10.1093/icvts/ivu157.Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. doi:10.1371/journal.pmed.1000097.Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. doi:10.1371/journal.pmed.1000097.Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7(5):510-8. doi:10.1016/j.jcin.2014.01.158.Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7(5):510-8. doi:10.1016/j.jcin.2014.01.158.Sareen N, Baber U, Aquino M, et al. Mid-term outcomes of consecutive 998 cases of coronary atherectomy in contemporary clinical practice. J Interv Cardiol. 2017;30(4): 331-7. doi:10.1111/joic.12398.Sareen N, Baber U, Aquino M, et al. Mid-term outcomes of consecutive 998 cases of coronary atherectomy in contemporary clinical practice. J Interv Cardiol. 2017;30(4): 331-7. doi:10.1111/joic.12398.Thygesen K, Alpert JS, White HD. Universal Definition of Myocardial Infarction. Circulation. 2007;116(22):2634-53. doi:10.1161/CIRCULATIONAHA.107.187397.Thygesen K, Alpert JS, White HD. Universal Definition of Myocardial Infarction. Circulation. 2007;116(22):2634-53. doi:10.1161/CIRCULATIONAHA.107.187397.Shlofmitz E, Meraj P, Jauhar R, et al. Safety of orbital atherectomy in patients with left ventricular systolic dysfunction. J Interv Cardiol. 2017;30(5):415-20. doi:10.1111/joic.12405.Shlofmitz E, Meraj P, Jauhar R, et al. Safety of orbital atherectomy in patients with left ventricular systolic dysfunction. J Interv Cardiol. 2017;30(5):415-20. doi:10.1111/joic.12405.Lee MS, Shlofmitz E, Kong J, et al. Outcomes of patients with severely calcified aorto-ostial coronary lesions who underwent orbital atherectomy. J Interv Cardiol. 2018;31(1):15-20. doi:10.1111/joic.12432.Lee MS, Shlofmitz E, Kong J, et al. Outcomes of patients with severely calcified aorto-ostial coronary lesions who underwent orbital atherectomy. J Interv Cardiol. 2018;31(1):15-20. doi:10.1111/joic.12432.Meraj PM, Shlofmitz E, Kaplan B, et al. Clinical outcomes of atherectomy prior to percutaneous coronary intervention: A comparison of outcomes following rotational versus orbital atherectomy (COAP-PCI study). J Interv Cardiol. 2018;31(4):478-85. doi:10.1111/joic.12511.Meraj PM, Shlofmitz E, Kaplan B, et al. Clinical outcomes of atherectomy prior to percutaneous coronary intervention: A comparison of outcomes following rotational versus orbital atherectomy (COAP-PCI study). J Interv Cardiol. 2018;31(4):478-85. doi:10.1111/joic.12511.Chambers JW, Warner C, Cortez J, et al. Outcomes after Atherectomy Treatment of Severely Calcified Coronary Bifurcation Lesions: A Single Center Experience. Cardiovasc Revasc Med. 2019;20(7):569-72. doi:10.1016/j.carrev.2018.08.017.Chambers JW, Warner C, Cortez J, et al. Outcomes after Atherectomy Treatment of Severely Calcified Coronary Bifurcation Lesions: A Single Center Experience. Cardiovasc Revasc Med. 2019;20(7):569-72. doi:10.1016/j.carrev.2018.08.017.Barrett C, Warsavage T, Kovach C, et al. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program. Catheter Cardiovasc Interv. 2021;97(2):E219-E226. doi:10.1002/ccd.28971.Barrett C, Warsavage T, Kovach C, et al. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program. Catheter Cardiovasc Interv. 2021;97(2):E219-E226. doi:10.1002/ccd.28971.Sturm R, Armstrong EJ, Benhuri B, et al. Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter Analysis. Cardiovasc Revasc Med. 2021;26:34-8. doi:10.1016/j.carrev.2020.10.023.Sturm R, Armstrong EJ, Benhuri B, et al. Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter Analysis. Cardiovasc Revasc Med. 2021;26:34-8. doi:10.1016/j.carrev.2020.10.023.Qiu Z, Auchoybur Merveesh L, Xu Y, et al. The midterm results of coronary endarterectomy in patients with diffuse coronary artery disease. J Cardiothorac Surg. 2018; 13(1):90. doi:10.1186/s13019-018-0776-8.Qiu Z, Auchoybur Merveesh L, Xu Y, et al. The midterm results of coronary endarterectomy in patients with diffuse coronary artery disease. J Cardiothorac Surg. 2018; 13(1):90. doi:10.1186/s13019-018-0776-8.Акчурин Р.С., Ширяев А.А., Галяутдинов Д.М. и др. Годичные результаты коронарного шунтирования у пациентов с кальцинозом целевых коронарных артерий. Патология кровообращения и кардиохирургия. 2022;26(1):55-65. doi:10.21688/1681-3472-2022-1-55-65.Akchurin RS, Shiryaev AA, Galayutdinov DM, et al. 1-year outcomes results of coronary artery bypass grafting in patients with target artery distal calcinosis. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2022;26(1):55-65. (In Russ).Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019;40(3):237-69. doi:10.1016/j.jacc.2018.08.1038.Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019;40(3):237-69. doi:10.1016/j.jacc.2018.08.1038.Tiemuerniyazi X, Yan H, Song Y, et al. Mid-term outcomes of coronary endarterectomy combined with coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2021;32(2):188-95. doi:10.1093/icvts/ivaa252.Tiemuerniyazi X, Yan H, Song Y, et al. Mid-term outcomes of coronary endarterectomy combined with coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2021;32(2):188-95. doi:10.1093/icvts/ivaa252.Ellouze M, Bouchard D, Pham M, et al. Coronary endarterectomy in patients with diffuse coronary artery disease: assessment of graft patency with computed tomography angiography. Can J Surg. 2022;65(5):E635-E641. doi:10.1503/cjs.011121.Ellouze M, Bouchard D, Pham M, et al. Coronary endarterectomy in patients with diffuse coronary artery disease: assessment of graft patency with computed tomography angiography. Can J Surg. 2022;65(5):E635-E641. doi:10.1503/cjs.011121.Nishigawa K, Fukui T, Takaki J, et al. Coronary endarterectomy for diffusely diseased coronary artery: An ace in the hole in coronary artery surgery. JTCVS Tech. 2021;10:133-7. doi:10.1016/j.xjtc.2021.03.018.Nishigawa K, Fukui T, Takaki J, et al. Coronary endarterectomy for diffusely diseased coronary artery: An ace in the hole in coronary artery surgery. JTCVS Tech. 2021;10:133-7. doi:10.1016/j.xjtc.2021.03.018.Baber U.Coronary Artery Calcification and Mortality After Revascularization: Look Beyond the Heart. JACC Cardiovasc Interv. 2022;15(2):205-7. doi:10.1016/j.jcin.2021.11.008.Baber U.Coronary Artery Calcification and Mortality After Revascularization: Look Beyond the Heart. JACC Cardiovasc Interv. 2022;15(2):205-7. doi:10.1016/j.jcin.2021.11.008.Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-38. doi:10.1016/S0140-6736(13)60141-5.Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-38. doi:10.1016/S0140-6736(13)60141-5.Thuijs DJFM, Kappetein AP, Serruys PW, et al. SYNTAX Extended Survival Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325-34. doi:10.1016/S0140-6736(19)31997-X.Thuijs DJFM, Kappetein AP, Serruys PW, et al. SYNTAX Extended Survival Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325-34. doi:10.1016/S0140-6736(19)31997-X.

The authors declare that there are no conflicts of interest present.